Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Apixaban Isopropyl Ester Impurity

● Auf Lager

Katalog-Nr.::	VL3170018
CAS-Nr.::	N/A
Summenformel::	C28H30N4O5
Molare Masse::	502.56 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Apixaban Isopropyl Ester Impurity

Parent drug

Apixaban

IUPAC-Name

4, 5, 6, 7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3, 4-c]pyridine-3-carboxylic acid isopropyl ester

Synonyme

N/A

SMILES

O=C1CCCCN1C2=CC=C(N3CCC(C(C(OC(C)C)=O)=NN4C5=CC=C(OC)C=C5)=C4C3=O)C=C2

Beschreibung

Apixaban Isopropyl Ester Impurity (CAS No: N/A) or 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid isopropyl ester, is a a pyrazole derivative, it acts as Inhibition of factor Xa leads to decreased conversion of factor II to IIa, resulting in decreased thrombin generation and used in treatment and prevent strokes or blood clots.

References

Budovich, Aliaksandr, et al. “Role of Apixaban (Eliquis) in the Treatment and Prevention of Thromboembolic Disease.” Pharmacy and Therapeutics, vol. 38, no. 4, 1 Apr. 2013, pp. 206–231, www.ncbi.nlm.nih.gov/pmc/articles/PMC3684191/#b5-ptj3804206.